Eszopiclone
Products in Health Canada’s databases that list Eszopiclone as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 9
- 9 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 7
- Products in all
- 9
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| LUNESTA (1 MG) | 02453207 | Marketed | Knight Therapeutics Inc. | |
| LUNESTA (2 MG) | 02453215 | Marketed | Knight Therapeutics Inc. | |
| LUNESTA (3 MG) | 02453223 | Marketed | Knight Therapeutics Inc. | |
| M-ESZOPICLONE (1 MG) | 02551187 | Marketed | Mantra Pharma Inc. | |
| M-ESZOPICLONE (2 MG) | 02551195 | Marketed | Mantra Pharma Inc. | |
| M-ESZOPICLONE (3 MG) | 02551209 | Marketed | Mantra Pharma Inc. | |
| MAR-ESZOPICLONE (1 MG) | 02549433 | Marketed | Marcan Pharmaceuticals Inc. | |
| MAR-ESZOPICLONE (2 MG) | 02549441 | Marketed | Marcan Pharmaceuticals Inc. | |
| MAR-ESZOPICLONE (3 MG) | 02549468 | Marketed | Marcan Pharmaceuticals Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- LUNESTAJanuary 20, 2026 · NOC 36754
- M-ESZOPICLONEAugust 23, 2024 · NOC 33869
- MAR-ESZOPICLONEJuly 4, 2024 · NOC 33563
- LUNESTAApril 18, 2024 · NOC 33079
- LUNESTAOctober 12, 2022 · NOC 29178
- LUNESTAApril 14, 2020 · NOC 23439
- LUNESTAMarch 17, 2016 · NOC 17891